2026 NPPES data Retina Specialist (Ophthalmology) Physician NPI 1669699518 M.D
Verify on CMS →

RAJEEV RAMCHANDRAN, M.D

Retina Specialist (Ophthalmology) Physician in ROCHESTER, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
359
Medicare Part D claims · 89 beneficiaries · Retina Specialist (Ophthalmology) Physician avg: 558
Generic prescribing
62%
generic claims · 38% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
95.0565/100
▲ 12 pts above national avg 83.1 · [object Object]

What the federal data shows

RAJEEV RAMCHANDRAN, M.D reported a CMS MIPS final score of 95.0565/100 — above the 83.1 national average — and filed 359 Medicare Part D claims in 2023.

95.0565/100
MIPS score · +12 vs avg
359
Part D claims, 2023
62%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

RAJEEV RAMCHANDRAN, M.D's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

95 Top 21% higher than 79% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

RAJEEV RAMCHANDRAN, M.D practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about RAJEEV RAMCHANDRAN, M.D?

High performer (top quartile)

NPI registry status

Active

Issued 04/20/2007

NPI 1669699518

Primary specialty

Retina Specialist (Ophthalmology) Physician

Niche

913 US NPIs in this specialty

Medicare Part D claims

359 36% vs specialty avg

2023 prescription claims

Specialty avg: 558

MIPS final score

95.0565/100 11.956500000000005% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in New York

How Retina Specialist (Ophthalmology) Physician compares to other specialties among New York providers

New York providers

Retina Specialist (Ophthalmology) Physician share within New York

1. Retina Specialist (Ophthalmology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Retina Specialist (Ophthalmology) Physician share within New York

Medicare quality performance — MIPS

RAJEEV RAMCHANDRAN, M.D's 2023 MIPS final score plotted against the Retina Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
95.0565/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Retina Specialist (Ophthalmology) Physician) — 95.0565/100 vs national avg 83.1

0%100%National avg83%95.1%
MIPS final score (Retina Specialist (Ophthalmology) Physician) — 95.0565/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

RAJEEV RAMCHANDRAN, M.D appears in the CMS NPPES registry as a Retina Specialist (Ophthalmology) Physician provider holding M.D credentials at 601 ELMWOOD AVE, ROCHESTER, NY, 14642, with a listed phone of (585) 275-0378. NPI 1669699518 was issued on 04/20/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what RAMCHANDRAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 359 prescription claims written by this provider, covering 89 Medicare beneficiaries and totaling roughly $14K in drug spend, split 38% brand-name and 62% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 95.0565/100 for the 2023 performance year (Quality 74.7357), compared with the national average of 83.1.

Retina Specialist (Ophthalmology) Physician is a narrow specialty nationwide, with 913 enrolled providers across 48 states and an average of 558 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

601 ELMWOOD AVE
ROCHESTER, NY 14642

Provider Details

NPI 1669699518
Specialty Retina Specialist (Ophthalmology) Physician
Credentials M.D
Gender Male
NPI Issued 04/20/2007

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

95.0565
Final Score
Avg: 83.1
74.7357
Quality
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where RAJEEV RAMCHANDRAN, M.D bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

RETINA SERVICES OF THE UNIVERSITY OF ROCHESTER
ROCHESTER, NY

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to RAJEEV RAMCHANDRAN, M.D. To verify RAJEEV RAMCHANDRAN, M.D's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

RAJEEV RAMCHANDRAN, M.D — brand share 38.0%
Specialty average (est.)

38% brand-name claims vs 62% generic, on 359 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

359
Total Claims
$14K
Total Drug Cost
89
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
462
Total Day Supply
11,612
Brand vs Generic
38% brand / 62% generic
Brand Drug Cost
$8K
Generic Drug Cost
$6K

Patient Demographics

Average Patient Age
68.3 years
Avg HCC Risk Score
1.92
Gender Split
55% female / 45% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What RAJEEV RAMCHANDRAN, M.D prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Prednisolone Acetate
103
Ketorolac Tromethamine
68
Atropine Sulfate
44
Neomycin-Polymyxin-Dexameth
Neomycin/Polymyxin B/Dexametha
43
Moxifloxacin
Moxifloxacin Hcl
17
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
14
Timolol Maleate
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Retina Specialist (Ophthalmology) Physician Overview

How RAJEEV RAMCHANDRAN, M.D fits within the Retina Specialist (Ophthalmology) Physician landscape nationally.

913
Retina Specialist (Ophthalmology) Physician Providers in US
48
States with Retina Specialist (Ophthalmology) Physician
558
Avg Claims per Provider

RAJEEV RAMCHANDRAN, M.D's 359 claims are below the specialty average of 558.

Nearby Retina Specialist (Ophthalmology) Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as RAMCHANDRAN.

Compare Retina Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is RAJEEV RAMCHANDRAN, M.D's specialty?
RAJEEV RAMCHANDRAN, M.D specializes in Retina Specialist (Ophthalmology) Physician and practices in ROCHESTER, New York. Credentials: M.D.
How much does RAJEEV RAMCHANDRAN, M.D prescribe under Medicare Part D?
In 2023, RAJEEV RAMCHANDRAN, M.D wrote 359 Medicare Part D claims totaling $14K in drug costs for 89 beneficiaries.
What is RAJEEV RAMCHANDRAN, M.D's Medicare quality score?
RAJEEV RAMCHANDRAN, M.D has a CMS MIPS Final Score of 95.0565/100 (Quality: 74.7357). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is RAJEEV RAMCHANDRAN, M.D located?
RAJEEV RAMCHANDRAN, M.D is located at 601 ELMWOOD AVE, ROCHESTER, NY, 14642. Phone: (585) 275-0378.
What is RAJEEV RAMCHANDRAN, M.D's NPI number?
RAJEEV RAMCHANDRAN, M.D's National Provider Identifier (NPI) is 1669699518, issued on 04/20/2007.
Does RAJEEV RAMCHANDRAN, M.D prescribe more brand-name or generic drugs?
RAJEEV RAMCHANDRAN, M.D's prescribing is 38% brand-name and 62% generic drugs by claim count, with $8K in brand drug costs.
How many Retina Specialist (Ophthalmology) Physician providers are there in the US?
There are 913 Retina Specialist (Ophthalmology) Physician providers across 48 states in the US. The average Retina Specialist (Ophthalmology) Physician provider writes 558 Medicare Part D claims per year.
What drugs does RAJEEV RAMCHANDRAN, M.D prescribe most often?
Based on 2023 Medicare Part D data, RAJEEV RAMCHANDRAN, M.D's most frequently prescribed drugs include Prednisolone Acetate, Ketorolac Tromethamine, Atropine Sulfate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does RAJEEV RAMCHANDRAN, M.D accept Medicare?
RAJEEV RAMCHANDRAN, M.D appears in CMS Medicare data with 359 Part D claims and 89 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify RAJEEV RAMCHANDRAN, M.D's credentials?
RAJEEV RAMCHANDRAN, M.D's NPI is 1669699518 with credentials M.D. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology